Your browser doesn't support javascript.
loading
CDK8 and CDK19: positive regulators of signal-induced transcription and negative regulators of Mediator complex proteins.
Chen, Mengqian; Li, Jing; Zhang, Li; Wang, Lili; Cheng, Chen; Ji, Hao; Altilia, Serena; Ding, Xiaokai; Cai, Guoshuai; Altomare, Diego; Shtutman, Michael; Byrum, Stephanie D; Mackintosh, Samuel G; Feoktistov, Alexey; Soshnikova, Nataliya; Mogila, Vladislav A; Tatarskiy, Victor; Erokhin, Maksim; Chetverina, Darya; Prawira, Angga; Ni, Yi; Urban, Stephan; McInnes, Campbell; Broude, Eugenia V; Roninson, Igor B.
Afiliação
  • Chen M; Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA.
  • Li J; Senex Biotechnology, Inc. Columbia, SC 29208, USA.
  • Zhang L; Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA.
  • Wang L; Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA.
  • Cheng C; Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA.
  • Ji H; Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA.
  • Altilia S; Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA.
  • Ding X; Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA.
  • Cai G; Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA.
  • Altomare D; Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA.
  • Shtutman M; Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA.
  • Byrum SD; Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA.
  • Mackintosh SG; Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
  • Feoktistov A; Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
  • Soshnikova N; Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russian Federation.
  • Mogila VA; Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russian Federation.
  • Tatarskiy V; Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russian Federation.
  • Erokhin M; Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russian Federation.
  • Chetverina D; Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russian Federation.
  • Prawira A; Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russian Federation.
  • Ni Y; Department of Infectious Diseases, University Hospital of Heidelberg, Heidelberg, Germany.
  • Urban S; Department of Infectious Diseases, University Hospital of Heidelberg, Heidelberg, Germany.
  • McInnes C; Department of Infectious Diseases, University Hospital of Heidelberg, Heidelberg, Germany.
  • Broude EV; Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA.
  • Roninson IB; Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA.
Nucleic Acids Res ; 51(14): 7288-7313, 2023 08 11.
Article em En | MEDLINE | ID: mdl-37378433
ABSTRACT
We have conducted a detailed transcriptomic, proteomic and phosphoproteomic analysis of CDK8 and its paralog CDK19, alternative enzymatic components of the kinase module associated with transcriptional Mediator complex and implicated in development and diseases. This analysis was performed using genetic modifications of CDK8 and CDK19, selective CDK8/19 small molecule kinase inhibitors and a potent CDK8/19 PROTAC degrader. CDK8/19 inhibition in cells exposed to serum or to agonists of NFκB or protein kinase C (PKC) reduced the induction of signal-responsive genes, indicating a pleiotropic role of Mediator kinases in signal-induced transcriptional reprogramming. CDK8/19 inhibition under basal conditions initially downregulated a small group of genes, most of which were inducible by serum or PKC stimulation. Prolonged CDK8/19 inhibition or mutagenesis upregulated a larger gene set, along with a post-transcriptional increase in the proteins comprising the core Mediator complex and its kinase module. Regulation of both RNA and protein expression required CDK8/19 kinase activities but both enzymes protected their binding partner cyclin C from proteolytic degradation in a kinase-independent manner. Analysis of isogenic cell populations expressing CDK8, CDK19 or their kinase-inactive mutants revealed that CDK8 and CDK19 have the same qualitative effects on protein phosphorylation and gene expression at the RNA and protein levels, whereas differential effects of CDK8 versus CDK19 knockouts were attributable to quantitative differences in their expression and activity rather than different functions.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinases Ciclina-Dependentes / Complexo Mediador Tipo de estudo: Qualitative_research Limite: Humans Idioma: En Revista: Nucleic Acids Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinases Ciclina-Dependentes / Complexo Mediador Tipo de estudo: Qualitative_research Limite: Humans Idioma: En Revista: Nucleic Acids Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos